Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?

作者: Surajit Das , Wai Kiong Ng , Reginald B.H. Tan

DOI: 10.1016/J.EJPS.2012.05.010

关键词:

摘要: In recent years, solid lipid nanoparticles (SLNs) and nanostructured carriers (NLCs) are among the popular research topics for delivery of lipophilic drugs. Although SLNs have demonstrated several beneficial properties as drug-carrier, limited drug-loading expulsion drug during storage led to development NLCs. However, superiority NLCs over has not been fully established yet due contradictory results. this study, were developed using clotrimazole model drug. Size, polydispersity index (PI), zeta potential (ZP), (L), encapsulation efficiency (EE), scanning electron microscopy (SEM), differential calorimetry (DSC), X-ray diffractometry (XRD), release stability compared. Critical process parameters exhibited significant impact on nanoparticles' properties. PI, ZP EE 82%, respectively. SEM images revealed spherical shaped particles (≈ 100 nm). DSC XRD studies indicated slight difference between well disappearance crystalline peak(s) encapsulated faster than at low drug-loading, whereas there was no in from high drug-loading. sustained/prolonged observed both formulations. Furthermore, study suggests that experiment should be designed considering final application (topical/oral/parenteral) product. Regarding stability, showed better (in terms size, L) 25°C. Moreover, profile after 3 months compare fresh NLCs, while change rate case SLNs. Therefore, an edge

参考文章(34)
Yong Cs, Choi Hg, Yi Sj, Prabagar B, Rhee Jd, Kim Ja, Park Bc, Lyoo Ws, Li Dx, Yoo Bk, Woo Js, The effect of beta-cyclodextrin complexation on the bioavailability and hepatotoxicity of clotrimazole. Die Pharmazie. ,vol. 62, pp. 756- 759 ,(2007)
Rainer H Müller, Karsten Mäder, Sven Gohla, Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 50, pp. 161- 177 ,(2000) , 10.1016/S0939-6411(00)00087-4
Surajit Das, Wai Kiong Ng, Reginald B.H. Tan, Development and In Vitro Evaluations of a Lipid Nanoparticle Formulation Containing Tretinoin NanoFormulation. pp. 38- 52 ,(2012) , 10.1039/9781849735247-00038
R.H Müller, M Radtke, S.A Wissing, Nanostructured lipid matrices for improved microencapsulation of drugs International Journal of Pharmaceutics. ,vol. 242, pp. 121- 128 ,(2002) , 10.1016/S0378-5173(02)00180-1
C. Freitas, R.H. Müller, Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 47, pp. 125- 132 ,(1999) , 10.1016/S0939-6411(98)00074-5
A HANAFY, H SPAHNLANGGUTH, G VERGNAULT, P GRENIER, M TUBICGROZDANIS, T LENHARDT, P LANGGUTH, Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Advanced Drug Delivery Reviews. ,vol. 59, pp. 419- 426 ,(2007) , 10.1016/J.ADDR.2007.04.005
Chih-Chieh Chen, Tung-Hu Tsai, Zih-Rou Huang, Jia-You Fang, Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 74, pp. 474- 482 ,(2010) , 10.1016/J.EJPB.2009.12.008
Surajit Das, Anumita Chaudhury, Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery Aaps Pharmscitech. ,vol. 12, pp. 62- 76 ,(2011) , 10.1208/S12249-010-9563-0
Constantia E. Kast, Claudia Valenta, Martina Leopold, Andreas Bernkop-Schnürch, Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. Journal of Controlled Release. ,vol. 81, pp. 347- 354 ,(2002) , 10.1016/S0168-3659(02)00077-9